• 1
    Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives in innate immunity. Science 1999; 284: 1313.
  • 2
    Medzhitov R, Janeway C Jr. Innate immune recognition: mechanisms and pathways. Immunol Rev 2000; 173: 89.
  • 3
    Medzhitov R, Janeway CA Jr. Advances in Immunology: innate immunity. N Engl J Med 2000; 343: 338.
  • 4
    Davis MM. T cell receptor gene diversity and selection. Annu Rev Biochem 1990; 59: 475.
  • 5
    Alt FW, Oltz EM, Young F, Gorman J, Taccioli G, Chen J. VDJ recombination. Immunol Today 1992; 13: 306.
  • 6
    Medzhitov R, Janeway CA Jr. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 1997; 9: 4.
  • 7
    Medzhitov R, Janeway CA Jr. Innate immune recognition and control of adaptive immune responses. Semin Immunol 1998; 10: 351.
  • 8
    Kopp EB, Medzhitov R. The Toll-receptor family and control of innate immunity. Curr Opin Immunol 1999; 11: 13.
  • 9
    Chen W, Syldath U, Bellmann K, Burkart V, Kolb H. Human 60-kDa heat-shock protein: a danger signal to the innate immune system. J Immunol 1999; 162: 3212.
  • 10
    Goerdt S, Politz O, Schledzewski K et al. Alternative versus classical activation of macrophages. Pathobiology 1999; 67: 222.
  • 11
    Wilson R, Chen C, Ratcliffe NA. Innate immunity in insects. the role of multiple, endogenous serum lectins in the recognition of foreign invaders in the cockroach, Blaberus discoidalis. J Immunol 1999; 162: 1590.
  • 12
    Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001; 410: 1103.
  • 13
    Laskowski IA, Hancock WW, Pratchke J, Wilhelm MJ, Tilney NL. Accelerated graft dysfunction in renal isografts from non-heart-beating donors. Transplant Proc 2001; 33: 909.
  • 14
    Tilney NL, Paz D, Ames J, Gasser M, Laskowski I, Hancock WW. Ischemia-reperfusion injury. Transplant Proc 2001; 33: 843.
  • 15
    He H, Stone JR, Perkins DL. Analysis of robust innate immune response following transplantation in the absence of adaptive immunity. Transplantation 2002; 73: 85361.
  • 16
    Corry RJ, Winn HJ, Russell PS 1973 Heart transplantation in congenic strains of mice. Transplant Proc 2001; 5: 733.
  • 17
    Hallensleben W, Biro L, Sauder C, Hausmann J, Asensio VC, Campbell IL, Staeheli P. A polymorphism in the mouse crg-2/IP-10 gene complicates chemokine gene expression analysis using a commercial ribonuclease protection assay. J Immunol Meth 2000; 234: 149.
  • 18
    Billingham ME, Cary NR, Hammond ME et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990; 9: 587.
  • 19
    Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998; 95: 14863.
  • 20
    Baldwin WM, 3rd, Larsen C.P, Fairchild , R.L. Innate immune responses to transplants: a significant variable with cadaver donors. Immunity 2001; 14: 369.
  • 21
    Fairchild R.L, VanBuskirk AM, Kondo T, Wakely M.E, Orosz CG. Expression of chemokine genes during rejection and long-term acceptance of cardiac allografts. Transplantation 1997; 63:1807.
  • 22
    Kondo T, Morita K, Watarai Y, Auerbach MB, Taub DD, Novick AC, Toma H, Fairchild RL. Early increased chemokine expression and production in murine allogeneic skin grafts is mediated by natural killer cells. Transplantation 2000; 69: 969.
  • 23
    Li B, Hartono C, Ding R, Sharma VK et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001; 344: 947.
  • 24
    Sarwal MM, Jani A, Chang S et al. Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation. Hum Immunol 2001; 62: 21.
  • 25
    Hancock WW, Gao W, Csizmadia V, Faia KL, Shemmeri N, Luster AD. Donor-derived IP-10 initiates development of acute allograft rejection. J Exp Med 2001; 193: 975.
  • 26
    Le Page C, Genin P, Baines MG, Hiscott J. Interferon activation and innate immunity. Rev Immunogenetics 2000; 2: 374.
  • 27
    Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104: 487.
  • 28
    Endres R, Alimzhanov MB, Plitz T, Futterer A, Kosco-Vilbois MH, Nedospasov SA, Rajewsky K, Pfeffer K. Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells. J Exp Med 1999; 189: 159.
  • 29
    Hennemann B, Tam YK, Tonn T, Klingemann HG. Expression of SCM-1alpha/lymphotactin and SCM-1beta in natural killer cells is upregulated by IL-2 and IL-12. DNA Cell Biol 1999; 18: 565.
  • 30
    Rumsaeng V, Vliagoftis H, Oh CK, Metcalfe DD. Lymphotactin gene expression in mast cells following Fc (epsilon) receptor I aggregation: modulation by TGF-beta, IL-4, dexamethasone, and cyclosporin A. J Immunol 1997; 158: 1353.
  • 31
    Appay V, Rowland-Jones SL. RANTES. a versatile and controversial chemokine. Trends Immunol 2001; 22: 83.
  • 32
    Weiser MR, Williams JP, Moore FD Jr, Kobzik L, Ma M, Hechtman HB, Carroll MC. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 1996; 183: 2343.
  • 33
    Hori T, Sakaida H, Sato A, Nakajima T, Shida H, Yoshie O, Uchiyama T. Detection and delineation of CXCR-4 (fusin) as an entry and fusion cofactor for T-tropic [correction of T cell-tropic] HIV-1 by three different monoclonal antibodies. J Immunol 1998; 160: 180.